Skip to main content
. 2022 Feb 16;43(34):3213–3223. doi: 10.1093/eurheartj/ehac015

Figure 4.

Figure 4

Prevalence of statin intolerance in combined primary and secondary prevention studies. Note: D–L random-effects model was used.